Tharimmune, Inc. — Board/Management Information 2025

Apr 25, 2025

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) April 24, 2025

THARIMMUNE, INC.

(Exact name of registrant as specified in its charter)

Delaware	001-41210	84-2642541
(State
or other jurisdiction of
incorporation)	(Commission File
Number)	(I.
R. S. Employer Identification
No.)

1200 Route 22 East , Suite 2000

Bridgewater , NJ 08807

(Address of principal executive offices, including zip code)

(908) 955-3140

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

| ☐ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| --- | --- |
| ☐ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Securities registered pursuant to Section 12(b) of the Act:

| Title
of each class | Trading
Symbol(s) | Name
of each exchange on which registered |
| --- | --- | --- |
| Common
stock, $0.0001 par value | THAR | The
Nasdaq Stock Market LLC |

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

Item 8.01 Other Events.

On April 24, 2025, Leonard Mazur and Lynne Bui, MD notified the Board of Directors of Tharimmune, Inc. (the “Company”) that they will not seek re-election at the end of their terms and will retire from the Board at the Company’s 2025 Annual Meeting of Stockholders scheduled to be held on June 10, 2025. Both of their retirements will be effective on that date. Mr. Mazur’s and Dr. Bui’s retirement does not relate to any disagreements with the Company, its management or the Board of Directors.

Field: Page; Sequence: 2

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| Date:
April 25, 2025 |
| --- |
| /s/
Randy Milby |
| Randy
Milby |
| Chief
Executive Officer |

Field: Page; Sequence: 3; Options: Last

Field: /Page

Field: Set; Name: xdx; ID: xdx_08B_extensions eJxFjdEKgkAQRb/Afxj2OWqVfMjHpCKyCJHodcsplnRHZrfST+ovW5VouDAM9565QkzEhta6QobzMs+gwLqplEPI8YaM5oo+kW53Cfid411bx8q44fyBKXkGPRNPo/jijSH60hbLBOR8FnnFIBdJKOG4F0Hvp2RuukTjtKpAmRKOTA1rdIq78UOhWjJUd0PVCdlqMgmEUznaH4hkGMGBXupN/LCQZakIJsMEYsP0bHxq1To0PQmrCmtfZ0f6r+ALCadKkQ==